You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PH-ILD

Showing 1 - 25 of 1,713
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Hypertension, Interstitial Lung Disease Trial (Treprostinil Palmitil Inhalation Powder, Placebo)

Not yet recruiting
  • Pulmonary Hypertension
  • Interstitial Lung Disease
  • Treprostinil Palmitil Inhalation Powder
  • Placebo
  • (no location specified)
Jan 23, 2023

Patients With Interstitial Lung Disease for Earlier Detection

Not yet recruiting
  • Interstitial Lung Disease
  • Pulmonary Hypertension
  • Right heart catheterization (RHC)
  • (no location specified)
Mar 16, 2023

Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial (Inhaled Treprostinil)

Available
  • Pulmonary Hypertension
  • +2 more
  • Inhaled Treprostinil
  • (no location specified)
Oct 5, 2022

Pulmonary Hypertension, Interstitial Lung Disease Trial (LIQ861)

Not yet recruiting
  • Pulmonary Hypertension
  • Interstitial Lung Disease
  • LIQ861
  • (no location specified)
Nov 10, 2023

Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States

Completed
Has Results
  • Pulmonary Hypertension
  • +2 more
  • Inhaled Treprostinil
  • Placebo
  • Birmingham, Alabama
  • +96 more
Jul 21, 2022

Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmonary Fibrosis Trial in Kansas City

Recruiting
  • Interstitial Lung Disease
  • +4 more
    • Kansas City, Kansas
      The University of Kansas Medical Center
    Nov 5, 2022

    Interstitial Lung Disease Trial in Vancouver (concentrated beetroot juice (400mg of nitrate per serving), concentrated beetroot

    Recruiting
    • Interstitial Lung Disease
    • concentrated beetroot juice (400mg of nitrate per serving)
    • concentrated beetroot juice (trace amounts of nitrate per serving)
    • Vancouver, British Columbia, Canada
    • +1 more
    May 17, 2022

    Idiopathic Inflammatory Myopathy, Interstitial Lung Disease Trial in Xi'an (Mycophenolate Mofetil)

    Recruiting
    • Idiopathic Inflammatory Myopathy
    • Interstitial Lung Disease
    • Mycophenolate Mofetil
    • Xi'an, China
      Department of Rheumatology,the First Affiliated Hospital of Xi'a
    Nov 10, 2021

    Creation ofBiospecimen Repository From Interstitial Lung

    Recruiting
    • Interstitial Lung Disease
    • ILD
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Jan 11, 2022

    Upper and Lower Limb Maximal Exercise Capacities and Muscle

    Not yet recruiting
    • Interstitial Lung Disease
      • Ankara, Çankaya, Turkey
        Gazi University, Faculty of Health Sciences, Department of Physi
      Nov 21, 2023

      Interstitial Lung Disease, Scleroderma, Pulmonary Hypertension Trial in Tucson (Opsumit 10 Mg Tablet)

      Unknown status
      • Interstitial Lung Disease
      • +2 more
      • Opsumit 10 Mg Tablet
      • Tucson, Arizona
        University of Arizona
      Mar 29, 2019

      Phenotyping of the Out-of-proportion Pulmonary Hypertension

      Not yet recruiting
      • 1- Haemodynamic Phenotyping of the Out - of - Proportion PH to Guide Different Therapeutic Lines
      • Right sided heart catheterization
      • Assiut, Egypt
        Mahmoud Badwy
      Sep 18, 2023

      Rheumatoid Arthritis Related Interstitial Lung Disease

      Recruiting
      • Rheumatoid Arthritis Associated Interstitial Lung Disease
      • diagnosis of Interstitial lung disease
      • Chongqing, Chongqing, China
        Chongqing General Hospital
      Sep 7, 2023

      Antigen-specific T Cells in Antisynthetase Syndrome and

      Not yet recruiting
      • Antisynthetase Syndrome
      • BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
      • Dijon, France
      • +5 more
      Aug 2, 2023

      Interstitial Lung Disease Trial in Zurich (Incremental exercise test (IET), Constant work rate exercise test (CWRET))

      Not yet recruiting
      • Interstitial Lung Disease
      • Incremental exercise test (IET)
      • Constant work rate exercise test (CWRET)
      • Zurich, Switzerland
        Respiratory Clinic, University Hospital of Zurich
      May 17, 2021

      Liquid Biopsy to Enable Diagnostics and Monitoring for

      Recruiting
      • Lymphoproliferative Disorders
      • Lymphoproliferative Disorder Following Transplantation
      • Liquid biopsy
      • Basel, Switzerland
      • +5 more
      Mar 24, 2023

      Patients With Fibrotic Interstitial Lung Disease

      Not yet recruiting
      • Lung Diseases, Interstitial
        • Ridgefield, Connecticut
          Boehringer Ingelheim Pharmaceuticals, Inc.
        Jul 14, 2023

        Under Routine Clinical Practice in Taiwan to Observe Long-term

        Active, not recruiting
        • Idiopathic Pulmonary Fibrosis
        • Changhua, Taiwan
        • +26 more
        Jan 9, 2023

        Interstitial Lung Disease Trial in London (Dietetic intervention, Diet sheet ())

        Recruiting
        • Interstitial Lung Disease
        • Dietetic intervention
        • Diet sheet (placebo)
        • London, United Kingdom
          Royal Brompton Hospital
        Aug 23, 2023

        Interstitial Lung Disease Trial in Istanbul (Assessment)

        Completed
        • Interstitial Lung Disease
        • Assessment
        • Istanbul, Buyucekmece, Turkey
          İstanbul Üniversitesi-Cerrahpaşa
        Aug 15, 2023

        Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperoxia)

        Not yet recruiting
        • Interstitial Lung Disease
        • +4 more
        • Hyperoxia
        • (no location specified)
        Nov 1, 2022

        Tool for Interstitial Lung Disease in People With Rheumatoid

        Not yet recruiting
        • Arthritis, Rheumatoid
        • Lung Diseases, Interstitial
          • (no location specified)
          May 16, 2023

          OSA Trial

          Not yet recruiting
          • OSA
            • (no location specified)
            Sep 22, 2023

            Dyspnea Trial (Nitric Oxide, Placebo)

            Not yet recruiting
            • Dyspnea
            • Nitric Oxide
            • Placebo
            • (no location specified)
            Dec 5, 2022

            Interstitial Lung Disease Trial (efzofitimod 450 mg, efzofitimod 270 mg, Placebo)

            Not yet recruiting
            • Interstitial Lung Disease
            • efzofitimod 450 mg
            • +2 more
            • (no location specified)
            Jun 5, 2023